4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-042652
Chief Medical Officer sold 12,500 shares at an average $49.53 ($619,118)
- Chief Medical Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-07-15 | Option exercise | +10,186 | $1.58 | $16,043 | 25,963 | D |
| Pang Phillip Chief Medical Officer | 2020-07-15 | Option exercise | +2,314 | $5.18 | $11,975 | 28,277 | D |
| Pang Phillip Chief Medical Officer | 2020-07-15 | Sale | −5,000 | $49.54 | $247,683 | 23,277 | D |
| Pang Phillip Chief Medical Officer | 2020-07-15 | Sale | −7,500 | $49.52 | $371,435 | 15,777 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2020-07-01 | Option exercise · Employee Stock Option (Right to Buy) | −10,186 | 98,147 | D | ||
| Pang Phillip Chief Medical Officer | 2020-07-01 | Option exercise · Employee Stock Option (Right to Buy) | −2,314 | 74,024 | D | ||
| Open-market sales · 12,500 sh · avg $49.53 · $619,118 | |||||||
Loading xslF345X03/doc4.xml…